Self-Test and Near-Patient Testing (IVDR)
IVDR categories for devices intended for use by lay persons (self-test) or outside a laboratory environment by healthcare professionals (near-patient).
Definition
Article 2(5) defines a device for self-testing as an IVD intended to be used by lay persons, including in home settings. Article 2(6) defines a device for near-patient testing as intended for testing performed outside a laboratory environment, generally near to or at the side of the patient, by a health professional. Classification rules and usability requirements differ, and Annex I Section 19 sets out specific information-for-use requirements.What this means in practice
Self-test devices attract additional usability engineering scrutiny under IEC 62366-1 and, in most cases, a higher risk class than the equivalent professional-use device. Instructions for use must be understandable by a lay person with the education level of the intended user.Examples
- A rapid antigen test for COVID-19 purchased at a pharmacy for at-home use by an individual is a self-test device.
- A blood glucose meter used by a nurse during a home visit to check a patient's sugar levels is a near-patient testing device.
- A urine dipstick test kit used in a general practitioner's office to quickly screen for infections during a consultation is another example of near-patient testing.
- •Assuming similar regulatory pathways for professional-use and self-test devices; self-tests generally face stricter scrutiny due to the lay user base.
- •Underestimating the complexity of usability engineering for self-test devices, failing to meet the high standards required for lay person comprehension and safe use.
- •Neglecting the specific information-for-use requirements in Annex I Section 19 of the IVDR, which mandates clear, understandable instructions for both categories but especially for self-tests.
Frequently asked questions
Related terms
Grouped by themeEditor's picks
· Hand-selected related conceptsRegulation (EU) 2017/746 governing in vitro diagnostic medical devices in the EU.
EU IVDR's risk-based classification: Class A (lowest) to Class D (highest).
The systematic process, defined in IEC 62366-1, for analyzing, specifying, designing, verifying, and validating the usability of a medical device to minimize use-related risk.
More in Regulatory
· Same categoryFDA submission demonstrating a device is substantially equivalent to a legally marketed predicate.
Two alternative disclosure mechanisms in a 510(k) submission, a Summary is public on FDA's website; a Statement promises to share Safety & Effectiveness info on request.
Formal mechanism to ask FDA whether a product is a device and, if so, its likely classification.
510(k) variant that relies on FDA guidance, special controls, or recognized consensus standards.
Where this term appears across MedTech Terms.
Sources
3 sourcesEvery citation below opens the original document. Each is graded against our source-tier hierarchy so you can see what rests on binding law versus commentary.
- 1Regulation (EU) 2017/746, Article 2 and Annex I Section 19Tier 1 VerifiedEUR-Lexeur-lex.europa.eu
- 2European Commission - Medical DevicesTier 2 VerifiedEuropean Commissionhealth.ec.europa.eu
- 3IMDRF DocumentsTier 2 VerifiedIMDRFimdrf.org
Inline markers like [1] jump to the matching reference above.